Consultative Hemostasis and Thrombosis

Content: 
Copyright, Page iv
Dedication, Pages v-vi
Contributors, Pages vii-xi
Preface, Page xiii
Chapter 1 - The Consultative Process, Pages 1,3-15
Chapter 2 - A Systematic Approach to the Bleeding Patient: Correlation of Clinical Symptoms and Signs With Laboratory Testing, Pages 17-33
Chapter 3 - Endothelium, Pages 35-42
Chapter 4 - Hemophilia A and B, Pages 43,45-59
Chapter 5 - Less Common Congenital Disorders of Hemostasis, Pages 61-79
Chapter 6 - Nonhemophilic Inhibitors of Coagulation, Pages 81-95
Chapter 7 - von Willebrand Disease, Pages 97-109
Chapter 8 - General Aspects of Thrombocytopenia, Platelet Transfusions, and Thrombopoietic Growth Factors, Pages 111-122
Chapter 9 - Immune Thrombocytopenic Purpura, Pages 123-138
Chapter 10 - Congenital and Acquired Disorders of Platelet Function and Number, Pages 139-157
Chapter 11 - Purpura and Other Hematovascular Disorders, Pages 159-182
Chapter 12 - Disseminated Intravascular Coagulation, Pages 183-198
Chapter 13 - The Cross-Talk of Inflammation and Coagulation in Infectious Disease and Their Roles in Disseminated Intravascular Coagulation, Pages 199-209
Chapter 14 - Thrombophilia: Clinical and Laboratory Assessment and Management, Pages 211,213-244
Chapter 15 - Deep Vein Thrombosis and Pulmonary Embolism, Pages 245-256
Chapter 16 - Venous Thromboses at Unusual Sites, Pages 257-280
Chapter 17 - Prevention, Diagnosis, and Treatment of the Postphlebitic Syndrome, Pages 281-293
Chapter 18 - Thrombocytosis: Essential Thrombocythemia and Reactive Causes, Pages 295-318
Chapter 19 - The Antiphospholipid Syndrome: Clinical Presentation, Diagnosis, and Patient Management, Pages 319-338
Chapter 20 - Hemostatic Aspects of Cardiovascular Medicine, Pages 339-369
Chapter 21 - Risk Factors for Cardiovascular Disease and Arterial Thrombosis, Pages 371-378
Chapter 22 - Peripheral Arterial Disease, Pages 379-388
Chapter 23 - Thrombosis and Cancer, Pages 389-403
Chapter 24 - Thrombotic Thrombocytopenic Purpura, Pages 405-420
Chapter 25 - Heparin-Induced Thrombocytopenia, Pages 421-445
Chapter 26 - Antithrombotic Agents, Pages 447,449-460
Chapter 27 - Blood Component and Pharmacologic Therapy of Hemostatic Disorders, Pages 461-490
Chapter 28 - Thrombolytic Therapy, Pages 491-501
Chapter 29 - Topical Hemostatic Agents for Localized Bleeding, Pages 503-508
Chapter 30 - Therapeutic Apheresis, Pages 509-529
Chapter 31 - Vena Caval Filters, Pages 531-552
Chapter 32 - Thrombosis Related to Venous Access Devices, Pages 553-559
Chapter 33 - Dietary Supplements and Hemostasis, Pages 561-566
Chapter 34 - Thrombotic Risk of Contraceptives and Other Hormonal Therapies, Pages 567,569-580
Chapter 35 - Management of Bleeding Disorders in Pregnancy, Pages 581-591
Chapter 36 - Management of Thrombophilia and Antiphospholipid Syndrome During Pregnancy, Pages 593-609
Chapter 37 - Surgery and Hemostasis, Pages 611,613-634
Chapter 38 - Anticoagulation in the Perioperative Period, Pages 635-646
Chapter 39 - Hemostatic Alterations in Liver Disease and Liver Transplantation, Pages 647-659
Chapter 40 - Outpatient Anticoagulant Therapy, Pages 661-671
Chapter 41 - Point-of-Care Testing for Hemostatic Disorders, Pages 673-684
Chapter 42 - Prevention and Treatment of Venous Thromboembolism in Neurologic and Neurosurgical Patients, Pages 685-690
Chapter 43 - Hematologic Interventions for Acute Central Nervous System Disease, Pages 691-703
Chapter 44 - Atrial Septal Abnormalities and Cryptogenic Stroke, Pages 705-709
Chapter 45 - Pulmonary Hypertension: Thrombotic and Nonthrombotic in Origin, Pages 711-715
Chapter 46 - Hemorrhage Control and Thrombosis Following Severe Injury, Pages 717-722
Chapter 47 - Hemostatic Aspects of Sickle Cell Disease, Pages 723-735
Chapter 48 - Anticoagulation for Atrial Fibrillation and Prosthetic Cardiac Valves, Pages 737-746
Index, Pages 747-767